Investigators have developed STITCHR, a new gene editing tool that can insert therapeutic genes into specific locations without causing unwanted mutations. The system can be formulated completely as ...

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.

To grow, cancer tumors must hijack the immune system for their needs. One of the main tricks that most tumors use is to ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

Cellistic has launched the Echo-NK platform to enable the scalable manufacturing of allogeneic cell therapies to target multiple diseases.

Cellistic, a pioneer in induced pluripotent stem cells (iPSC)-based cell therapies, is launching the Echo™-NK platform to enable the scalable manufacturing of allogeneic cell therapies to target ...

Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.

CRISPR-Cas9 gene editing technology has emerged as one of the most transformative advancements in medicine and biotechnology.